The Institute of Cancer Research is offering a fully funded PhD
studentship in the Chromatin Regulation Team in the Section of
Structural Biology, including tuition fees and, stipend. The Chromatin
Regulation team is focused on understanding the molecular mechanisms
that determine the targeting and regulation of the enzyme complexes
involved in the epigenetic signalling process. This project will
determine how the mixed lineage leukaemia protein (MLL), the principle
methyltransferase in gene activation, is linked to the cell cycle by
its interaction with partner proteins such as the Host Cell Factor.
The studentship will give the opportunity to be trained in structural
biology techniques, principally X-ray crystallography, and a range of
biophysics and biochemistry approaches and apply this to a project in
the rapidly developing field of epigenetic control of gene
regulation. The Section of Structural Biology at ICR researches the
molecular basis of biological processes to improve our understanding
of the underlying mechanisms of cancer and applies this research to
the development of better cancer therapeutic agents.
The Institute of Cancer Research (a College of the University of
London) is a world-class cancer research organisation with HEFCE RAE
ratings of international excellence across all of its research
programmes. In partnership with The Royal Marsden NHS Foundation Trust
we form the largest comprehensive cancer centre in Europe, dedicated
to research that extends from epidemiology, genetics and molecular
biology, through drug discovery and development, to cancer diagnosis
and patient treatment. This makes us uniquely placed to work towards
our vision that people may live their lives free from the fear of
cancer as a life threatening disease.
Applications are invited from suitably-qualified graduates or final
year undergraduates who hold or expect to gain a first/upper second
class honours degree or equivalent in Biology or a related subject.
The successful candidate will undertake a four year research training
programme, starting in September 2009, under the guidance of Dr Jon
Wilson. The successful applicant will receive an annual stipend -
£19,096 (inner London - Chester Beatty Laboratories, Fulham Road).
For further details on this studentship please visit: www.icr.ac.uk/
phds. To apply please email regis...@icr.ac.uk for an application
form. The closing date for applications is 19th June 2009."
The Institute of Cancer Research: Royal Cancer Hospital, a charitable Company
Limited by Guarantee, Registered in England under Company No. 534147 with its
Registered Office at 123 Old Brompton Road, London SW7 3RP.
This e-mail message is confidential and for use by the addressee only. If the
message is received by anyone other than the addressee, please return the
message to the sender by replying to it and then delete the message from your
computer and network.
